Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperglycemia × Vildagliptin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 Breast 1

Conditions

Diabetes Mellitus, Type 2 2 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Hyperglycemia 1 Breast Neoplasms 1

Interventions

Insulin Glargine 4 Insulin 3 volagidemab 2 Metformin 2 Alpelisib 2 ziprasidone 1 olaparib 1 exemestane 1 Vildagliptin 1 Tamoxifen 1 Standard of Care 1 Olanzapine 1 Letrozole 1 Insulin Lispro 1 Insulin Aspart 1 Injections 1 Fulvestrant 1 DNA, Ribosomal 1 Control Groups 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04300790 2025-07-29

METALLICA

MedSIR

Phase 2 Completed

BreastEndocrine

Breast Neoplasms, Hyperglycemia, Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡